Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Neoplastic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06384235
What this trial is testing

Phase II Clinical Study of LTC004 in Patients With mCRC

Who this might be right for
Locally Advanced or Metastatic CRC
Letolab 30
Early research (Phase 1)Study completedNCT05322408
What this trial is testing

HCW9218 in Select Advanced Solid Tumors

Who this might be right for
Solid Tumor
Masonic Cancer Center, University of Minnesota 18
Early research (Phase 1)Study completedNCT00280176
What this trial is testing

Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer

Who this might be right for
Colorectal Cancer
UNC Lineberger Comprehensive Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00084617
What this trial is testing

Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+6 more
National Cancer Institute (NCI) 39
Testing effectiveness (Phase 2)UnknownNCT05103917
What this trial is testing

Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC

Who this might be right for
Triple Negative Breast Cancer
Abbisko Therapeutics Co, Ltd 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06132217
What this trial is testing

Simmitinib Plus SG001 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Shanghai Runshi Pharmaceutical Technology Co., Ltd 168
Early research (Phase 1)UnknownNCT05990621
What this trial is testing

Anti-CD70 CAR-T Cell Injection in Patients With CD70-positive Advanced Urologic Neoplasms

Who this might be right for
CD70-positive Advanced Urologic Neoplasms
Changhai Hospital 60
Large-scale testing (Phase 3)Study completedNCT00877006
What this trial is testing

Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study

Who this might be right for
Non-Hodgkin's LymphomaMantle Cell Lymphoma
Teva Branded Pharmaceutical Products R&D, Inc. 447
Testing effectiveness (Phase 2)Study completedNCT01636284
What this trial is testing

A Phase 2a Study of Modified Vaccinia Virus to Treat Sorafenib-naïve Advanced Liver Cancer

Who this might be right for
Hepatocellular Carinoma
Jennerex Biotherapeutics 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT07687433
What this trial is testing

Long-Course Concurrent Chemoradiotherapy With Adebrelimab and Apatinib as Neoadjuvant Therapy for Locally Advanced/Low-Lying Rectal Cancer Requiring Sphincter Preservation

Who this might be right for
Rectal Cancer Patients
Harbin Medical University 43
Testing effectiveness (Phase 2)Study completedNCT02280252
What this trial is testing

Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response

Who this might be right for
Breast Cancer
NYU Langone Health 69
Early research (Phase 1)WithdrawnNCT01941849
What this trial is testing

Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma

Who this might be right for
PhaeochromocytomaParaganglioma
University College, London
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07774247
What this trial is testing

Atezolizumab, Bevacizumab, and Tocilizumab in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
CHA University 51
Testing effectiveness (Phase 2)Study completedNCT00242749
What this trial is testing

IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma

Who this might be right for
Cancer of Head and Neck
AstraZeneca 47
Early research (Phase 1)Study completedNCT02031055
What this trial is testing

Study of the Mass Balance of Oral FTD and TPI as Components of TAS-102 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Taiho Oncology, Inc. 8
Early research (Phase 1)Study completedNCT00352443
What this trial is testing

S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
SWOG Cancer Research Network 66
Early research (Phase 1)Ended earlyNCT04729725
What this trial is testing

SAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIAL

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
M.D. Anderson Cancer Center 3
Early research (Phase 1)Ended earlyNCT06287463
What this trial is testing

Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway

Who this might be right for
Advanced Solid TumorRAF MutationRAS Mutation+7 more
Deciphera Pharmaceuticals, LLC 29
Testing effectiveness (Phase 2)Study completedNCT00354393
What this trial is testing

Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
The Cleveland Clinic 9
Early research (Phase 1)Study completedNCT03156114
What this trial is testing

This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.

Who this might be right for
NeoplasmsCarcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 172
Next Page